<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>米内网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-17T07:58:31+08:00</updated>
  <subtitle>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>20亿大品种“腰斩”，知名药企遭处罚！14款注射剂将带量采购，第四批集采2月3日开标</title>
    <updated>2021-01-17T07:53:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/_JH5QSwbo75kzd0vCUyQig</id>
    <link href="https://mp.weixin.qq.com/s/_JH5QSwbo75kzd0vCUyQig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批集采冲击550亿市场！扬子江、齐鲁、科伦……激战在即，6大超10亿注射剂抢手</title>
    <updated>2021-01-16T00:00:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/qXcfZxl854Qniwf7GCJ-og</id>
    <link href="https://mp.weixin.qq.com/s/qXcfZxl854Qniwf7GCJ-og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药企“爆雷”5亿净利润没了，上市近10年首亏！去年8家扭亏，誉衡、亚太巨亏超20亿翻盘</title>
    <updated>2021-01-15T16:15:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/hK5W_Vn0-ddq1H2LUHpY9A</id>
    <link href="https://mp.weixin.qq.com/s/hK5W_Vn0-ddq1H2LUHpY9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【审评】恒瑞、海思科……围攻8亿原研药！扬子江、石药超10家药企报产</title>
    <updated>2021-01-15T16:15:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/1xj3RZrVQn-EPjFbhDNERA</id>
    <link href="https://mp.weixin.qq.com/s/1xj3RZrVQn-EPjFbhDNERA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【获批】2亿抗菌药注射剂！石四药拿下首家过评</title>
    <updated>2021-01-15T16:15:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/mEiISK3Im9Xb3GmCf-YyPg</id>
    <link href="https://mp.weixin.qq.com/s/mEiISK3Im9Xb3GmCf-YyPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【关注】上市不到9个月董事长辞职！千亿市值医药股一天蒸发超百亿</title>
    <updated>2021-01-15T16:15:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/xsKhJMrWMiFetue5WZpEWg</id>
    <link href="https://mp.weixin.qq.com/s/xsKhJMrWMiFetue5WZpEWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扬子江大丰收！13个新品搅局350亿市场，仿制药申报NO.1，46个过评品种霸屏</title>
    <updated>2021-01-14T16:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/v6sc3uu5xU36bOqTaYD61Q</id>
    <link href="https://mp.weixin.qq.com/s/v6sc3uu5xU36bOqTaYD61Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】齐鲁将拿下首仿！18个重磅新品已获批</title>
    <updated>2021-01-14T16:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/lkTw32sxBxe6_XZ_OkyzSA</id>
    <link href="https://mp.weixin.qq.com/s/lkTw32sxBxe6_XZ_OkyzSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【聚焦】信立泰又有1类新药来袭，冲击拜耳30亿大品种</title>
    <updated>2021-01-14T16:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/bUm_Y19uERPn7Mv6ts_GvQ</id>
    <link href="https://mp.weixin.qq.com/s/bUm_Y19uERPn7Mv6ts_GvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【关注】厉害了复星！3个新品、1款创新药将获批</title>
    <updated>2021-01-14T16:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/5nt8YIXVaYDM_o_F_iGyQw</id>
    <link href="https://mp.weixin.qq.com/s/5nt8YIXVaYDM_o_F_iGyQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>千亿市场新药来袭，豪森获批，齐鲁、绿叶冲刺！石药猛攻脂质体，口溶膜成大热</title>
    <updated>2021-01-13T16:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/GDYQMqUJRCApIdancawUpg</id>
    <link href="https://mp.weixin.qq.com/s/GDYQMqUJRCApIdancawUpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】四川药企将拿下30亿抗肿瘤注射剂，赛诺菲占六成市场</title>
    <updated>2021-01-13T16:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/AumjX9PgNEy2rDl7719B1Q</id>
    <link href="https://mp.weixin.qq.com/s/AumjX9PgNEy2rDl7719B1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】输液龙头发威！注射剂新品将获批，与丽珠围攻原研</title>
    <updated>2021-01-13T16:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/Y1FWJiQwG4-NhxMUOCnwig</id>
    <link href="https://mp.weixin.qq.com/s/Y1FWJiQwG4-NhxMUOCnwig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【火爆】600+大咖齐聚IDC2021化学创新药研发与分析论坛</title>
    <updated>2021-01-13T16:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/6HMuq6TyrjlRpQaJ8vPztw</id>
    <link href="https://mp.weixin.qq.com/s/6HMuq6TyrjlRpQaJ8vPztw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中成药TOP20出炉！17个独家产品霸屏，3大品牌逆势增长，扬子江、康缘……抢食百亿市场</title>
    <updated>2021-01-12T17:03:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/_UjAf9milCCpz_JDnszkog</id>
    <link href="https://mp.weixin.qq.com/s/_UjAf9milCCpz_JDnszkog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【获批】30亿注射剂！奥赛康、朗天同日过评，阿斯利康失守半壁江山</title>
    <updated>2021-01-12T17:03:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/xYCmWw3lu_ncAkpPYAlZ-Q</id>
    <link href="https://mp.weixin.qq.com/s/xYCmWw3lu_ncAkpPYAlZ-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】银屑病“新星”本维莫德首进医保目录，外用治疗将迎新变革</title>
    <updated>2021-01-12T17:03:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/a7j791VHwMpabuOAbhFPZg</id>
    <link href="https://mp.weixin.qq.com/s/a7j791VHwMpabuOAbhFPZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【FDA】12月7款创新药来袭！2020年超50款获批上市</title>
    <updated>2021-01-12T17:03:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/Q-2fM91Oucr6r3fNHQQbKw</id>
    <link href="https://mp.weixin.qq.com/s/Q-2fM91Oucr6r3fNHQQbKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴、扬子江、科伦……84款注射剂过评！TOP10企业出炉，3大千亿市场遭“围攻”</title>
    <updated>2021-01-11T16:12:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/iqoj7HbGX2XkoC5DV5mRhA</id>
    <link href="https://mp.weixin.qq.com/s/iqoj7HbGX2XkoC5DV5mRhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【热议】“中道合盟”正式成立，华润江中联合渠道伙伴，共创医药商业合作新模式</title>
    <updated>2021-01-11T16:12:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/5912b5KcGRGYxv3b43KXxA</id>
    <link href="https://mp.weixin.qq.com/s/5912b5KcGRGYxv3b43KXxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>